Cargando…

Resistance of Cancer Cells to CTL-Mediated Immunotherapy

This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL c...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Bonavida, Benjamin (Editor ), Chouaib, Salem (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edición:1st ed. 2015.
Colección:Resistance to Targeted Anti-Cancer Therapeutics, 7
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-17807-3
003 DE-He213
005 20220118071031.0
007 cr nn 008mamaa
008 150620s2015 sz | s |||| 0|eng d
020 |a 9783319178073  |9 978-3-319-17807-3 
024 7 |a 10.1007/978-3-319-17807-3  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 571.978  |2 23 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Resistance of Cancer Cells to CTL-Mediated Immunotherapy  |h [electronic resource] /  |c edited by Benjamin Bonavida, Salem Chouaib. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a XIX, 353 p. 38 illus., 27 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Resistance to Targeted Anti-Cancer Therapeutics,  |x 2196-551X ;  |v 7 
520 |a This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined,  and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.  . 
650 0 |a Cancer. 
650 0 |a Medical microbiology. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 1 4 |a Cancer Biology. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Biomedical Research. 
700 1 |a Bonavida, Benjamin.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Chouaib, Salem.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319178080 
776 0 8 |i Printed edition:  |z 9783319178066 
776 0 8 |i Printed edition:  |z 9783319380674 
830 0 |a Resistance to Targeted Anti-Cancer Therapeutics,  |x 2196-551X ;  |v 7 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-17807-3  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)